Don't Ignore This Chart

Is there a Biotech Breakout in the Making?

 | 

The Biotech SPDR (XBI) is trading at a make-or-break point as it consolidates near the 40-week SMA. Traders should watch for the resolution of this consolidation because it will dictate the next directional move.

The chart below shows XBI surging from the mid 60s to the lower 90s and then stalling with a small triangle. Technically, a small triangle is like a pennant, which is a bullish continuation pattern. A pennant breakout would signal a resumption of the prior advance and target a move to new highs.

At this point, I have a bullish bias on XBI and expect a pennant breakout. Expectations, however, do not always go as expected so we need to consider the alternatives. The breakout zone turns into support in the 85 area. The ETF also bounced off the 85-87 zone two of the last four weeks with hollow (white) candlesticks. A break below this zone would be negative.

The indicator window shows weekly RSI (14) hovering above 50 to keep the momentum cup half full (bullish bias). A weekly close below 50 would signal a downturn in momentum and also be negative.


On Trend on YouTubeOn Trend on YouTube

Big Techs Lead as Banks Stall


- Arthur Hill, CMT

Senior Technical Analyst, StockCharts.com

Book: Define the Trend and Trade the Trend
Twitter: Follow @ArthurHill


Arthur Hill
About the author: , CMT, is a Senior Technical Analyst at StockCharts.com. He has written articles for numerous financial publications including Barrons and Stocks & Commodities magazine. Focusing predominantly on US equities and ETFs, his systematic approach of identifying trend, finding signals within the trend, and setting key price levels has made him an esteemed technician. In addition to his CMT designation, Arthur holds an MBA from the Cass Business School at City University in London. Learn More
Subscribe to Don't Ignore This Chart to be notified whenever a new post is added to this blog!
comments powered by Disqus